153 related articles for article (PubMed ID: 11928667)
1. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
2. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
3. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
[TBL] [Abstract][Full Text] [Related]
4. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ambroxol lozenges in the treatment of acute uncomplicated sore throat. EBM-based clinical documentation.
de Mey C; Peil H; Kölsch S; Bubeck J; Vix JM
Arzneimittelforschung; 2008; 58(11):557-68. PubMed ID: 19137906
[TBL] [Abstract][Full Text] [Related]
6. [The antioxidative and inflammation inhibiting properties of ambroxol].
Winsel K
Pneumologie; 1992 Sep; 46(9):461-75. PubMed ID: 1438126
[No Abstract] [Full Text] [Related]
7. [Treatment of sore throat pain with ambroxol-containing lozenges. Results of a pharmacy supported patient questionnaire].
Gillissen A; Hinkel U
Med Monatsschr Pharm; 2005 Nov; 28(11):399-403. PubMed ID: 16309023
[No Abstract] [Full Text] [Related]
8. Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M; Ragnoli B
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1119-29. PubMed ID: 18680446
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Ambroxol Lozenges in the Treatment of Acute Uncomplicated Sore Throat - a Pooled Analysis.
de Mey C; Koelsch S; Richter E; Pohlmann T; Sousa R
Drug Res (Stuttg); 2016 Jul; 66(7):384-92. PubMed ID: 27281448
[TBL] [Abstract][Full Text] [Related]
10. Antiinflammatory properties of ambroxol.
Beeh KM; Beier J; Esperester A; Paul LD
Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
[TBL] [Abstract][Full Text] [Related]
11. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
12. [ Erdosteine (Mucodox), oral administration].
J Pharm Belg; 2011 Jun; (2):55-6. PubMed ID: 21823444
[No Abstract] [Full Text] [Related]
13. Role of mucolytics in wet cough.
Dhar R
J Assoc Physicians India; 2013 May; 61(5 Suppl):23-7. PubMed ID: 24490447
[No Abstract] [Full Text] [Related]
14. Efficacy and Safety of an Oral Ambroxol Spray in the Treatment of Acute Uncomplicated Sore Throat.
de Mey C; Patel J; Lakha DR; Richter E; Koelsch S
Drug Res (Stuttg); 2015 Dec; 65(12):658-67. PubMed ID: 25782170
[TBL] [Abstract][Full Text] [Related]
15. Preventing exacerbations of chronic bronchitis and COPD.
Ekberg-Jansson A; Larsson S; Löfdahl CG
BMJ; 2001 May; 322(7297):1259-61. PubMed ID: 11375214
[No Abstract] [Full Text] [Related]
16. Mucolytics and antioxidant activity.
Strapková A; Nosál'ová G; Franová S
Life Sci; 1999; 65(18-19):1923-5. PubMed ID: 10576438
[TBL] [Abstract][Full Text] [Related]
17. [Clinical research on high-dosage ambroxol hydrochloride associated with ulinastatin in improvement of lung tissue injury of patients with paraquat poisoning].
Wang WS; Guan JY; Lu QL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Jan; 28(1):58-60. PubMed ID: 20426988
[No Abstract] [Full Text] [Related]
18. [Effectiveness of lasolvan in patients with chronic obstructive bronchitis and non-atopic bronchial asthma].
Aleksa VI; Prozorova VK; Mal'tseva NA; Shatikhina LN
Ter Arkh; 2001; 73(3):48-51. PubMed ID: 11417181
[TBL] [Abstract][Full Text] [Related]
19. Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.
Yan X; Song Y; Shen C; Xu W; Chen L; Zhang J; Liu H; Huang M; Lai G; Qian G; Wang J; Ye X; Zheng J; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():803-812. PubMed ID: 28405161
[TBL] [Abstract][Full Text] [Related]
20. Effects and mechanisms of ambroxol inhalation (Mucosolvan
Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
